Vanderbilt is suitable for the treatment of viral diseases and some malignant tumors, and has been approved for the treatment of chronic hepatitis B, hepatitis C and hairy cell leukemia. There are clinical trial results or literature reports that Vanderbilt is effective in treating viral diseases such as herpes zoster, condyloma acuminatum, epidemic hemorrhagic fever and respiratory syncytial virus pneumonia in children, and can be used to treat malignant tumors such as chronic myeloid leukemia, melanoma and lymphoma, as well as viral diseases and some malignant tumors. It has been approved for the treatment of chronic hepatitis B, hepatitis C and hairy cell leukemia. The clinical trial results or literature reports are effective for the treatment of viral diseases such as herpes zoster, condyloma acuminatum, epidemic hemorrhagic fever and respiratory syncytial virus pneumonia in children, and can be used for the treatment of malignant tumors such as chronic myeloid leukemia, melanoma and lymphoma.
At present, there are two dosage forms: powder injection and water injection, and water injection has obtained national patents.
Other products
Diagnostic reagents:
Prostate specific antigen (PSA) enzyme immunoassay kit
Morphine diagnostic kit
Dental equipment:
Yin Fu Silverfield
die
Research and development (R&D)
Sanyuan Gene was officially approved by the Ministry of Personnel to establish a postdoctoral research center in 20001year. The workstation has a high-quality professional R&D team with the background of modern medicine, pharmacy and biotechnology, and the GLP standard laboratory is fully equipped with advanced program-controlled fermentation system, protein purification system and related genetic engineering research and testing instruments, which can complete the research and development of biotechnology products such as molecular biology, protein purification, cell culture, quality control, pharmacology and toxicology, pharmaceutical research and clinical research. At the same time, using abundant network information resources, R&D Center has the rapid response ability to comprehensively track the research trends of new drugs at home and abroad. The overall strength of R&D is in a leading position in China.
Workstations are first-class scientific research institutions in the United Nations, such as Fudan University, Peking University, Tsinghua University, Peking Union Medical College and Academy of Military Medical Sciences. * * * Training postdoctoral students.
Research direction:
Genetically engineered protein drugs: drugs for treating viral diseases, tumors, cardiovascular diseases and immune diseases; Special preparations of protein drugs: long-acting preparations, sustained-release preparations, powder injections, transdermal absorbents, oral preparations, etc. Therapeutic antibody: humanized antibody used to treat tumors and autoimmune diseases. Gene diagnosis and gene therapy: gene diagnosis platform technology and kit, gene therapy method with application prospect; RNAi: new design and preparation research for viral diseases and tumors: stem cells and tissue engineering: basis and application of stem cells and tissue engineering: vaccines: innovative and alternative vaccines and preparations; Preclinical drug evaluation: developing new evaluation methods.